Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid.

Wild J, Grüner B, Metzger K, Kuhröber A, Pudollek HP, Hauser H, Schirmbeck R, Reimann J.

Vaccine. 1998 Feb;16(4):353-60.

PMID:
9607055
3.
4.

[The immunization effects of HBV core antigen and surface antigen fusion protein in mice].

Li L, Tian YJ, Shen H, Zhao XP, Yang DL.

Zhonghua Gan Zang Bing Za Zhi. 2009 Apr;17(4):275-9. Chinese.

PMID:
19403026
5.

Polyvalent DNA vaccines with bidirectional promoters.

Kwissa M, Unsinger J, Schirmbeck R, Hauser H, Reimann J.

J Mol Med (Berl). 2000;78(9):495-506.

PMID:
11140375
6.

DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.

Kuhöber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R.

J Immunol. 1996 May 15;156(10):3687-95.

PMID:
8621903
7.

Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.

Böhm W, Mertens T, Schirmbeck R, Reimann J.

Vaccine. 1998 May-Jun;16(9-10):949-54.

PMID:
9682342
8.

Cationic polymers that enhance the performance of HbsAg DNA in vivo.

Bos GW, Kanellos T, Crommelin DJ, Hennink WE, Howard CR.

Vaccine. 2004 Dec 9;23(4):460-9.

PMID:
15530694
9.

Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.

Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X.

J Virol Methods. 2007 Apr;141(1):41-8. Epub 2007 Jan 2. Erratum in: J Virol Methods. 2007 Sep;144(1-2):172.

PMID:
17197041
10.

Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.

Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S.

Vaccine. 2011 Aug 26;29(37):6342-51. doi: 10.1016/j.vaccine.2011.05.008. Epub 2011 May 19.

PMID:
21600951
11.

[Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].

Huang Z, Lu S, Liu N.

Zhonghua Yi Xue Za Zhi. 1999 Jun;79(6):456-9. Chinese.

PMID:
11715443
12.

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control.

Kwissa M, von Kampen vK, Zurbriggen R, Glück R, Reimann J, Schirmbeck R.

Vaccine. 2000 May 8;18(22):2337-44.

PMID:
10738089
13.

Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens.

Musacchio A, Rodriguez EG, Herrera AM, Quintana D, Muzio V.

Biochem Biophys Res Commun. 2001 Mar 30;282(2):442-6.

PMID:
11401479
14.
15.
16.

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.

Yin Y, Wu C, Song J, Wang J, Zhang E, Liu H, Yang D, Chen X, Lu M, Xu Y.

PLoS One. 2011;6(7):e22524. doi: 10.1371/journal.pone.0022524. Epub 2011 Jul 22.

17.

Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.

Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L.

Acta Virol. 1996 Nov-Dec;40(5-6):273-9.

PMID:
9171455
18.

Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.

Böcher WO, Dekel B, Schwerin W, Geissler M, Hoffmann S, Rohwer A, Arditti F, Cooper A, Bernhard H, Berrebi A, Rose-John S, Shaul Y, Galle PR, Löhr HF, Reisner Y.

Eur J Immunol. 2001 Jul;31(7):2071-9.

19.

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

Le Borgne S, Mancini M, Le Grand R, Schleef M, Dormont D, Tiollais P, Rivière Y, Michel ML.

Virology. 1998 Jan 20;240(2):304-15.

20.

Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.

Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.

J Virol Methods. 2008 Nov;153(2):142-8. doi: 10.1016/j.jviromet.2008.07.013. Epub 2008 Sep 3.

PMID:
18722475

Supplemental Content

Support Center